Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells

There is lots of evidence to support the critical involvement of mTOR signaling in the carcinogenesis of hepatocellular carcinoma (HCC). However, it has not been determined how the roles of individual mTORC1 and mTORC2 inhibitors played in the HCC therapeutics. We thus compared the effects of everol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong-Ok, Kim, Kee-Hwan, Song, In Sang, Cheon, Kwang-Sik, Kim, Ok-Hee, Lee, Sang Chul, Lee, Sang Kuon, Kim, Say-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356853/
https://www.ncbi.nlm.nih.gov/pubmed/27935857
http://dx.doi.org/10.18632/oncotarget.13808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356853/
https://www.ncbi.nlm.nih.gov/pubmed/27935857
http://dx.doi.org/10.18632/oncotarget.13808

Ejemplares similares